Literature DB >> 17687417

The limitations of sweat electrolyte reference intervals for the diagnosis of cystic fibrosis: a systematic review.

Avantika Mishra1, Ronda Greaves, John Massie.   

Abstract

The sweat test has been used for more than 50 years for the diagnosis of cystic fibrosis (CF) and remains an important diagnostic test in the genomic era. The currently used reference intervals for sweat electrolytes are applied to all patients regardless of age or sex. We performed a systematic review to summarise the studies with published reference values of sweat electrolyte concentrations for the diagnosis of CF. The MEDLINE (from 1950), EMBASE (from 1980) and PubMed (from 1950) databases were searched for English language studies. An abstract was also found by hand-searching. The search generated 1136 articles that matched the search key terms. Of these, 17 studies that contained data on sweat electrolyte concentrations were included in the analysis. Among these, seven studies did not perform the sweat test in accordance with current international and Australian guidelines. Of the ten remaining studies, four reported both the sweat sodium and chloride concentrations and six reported sweat chloride concentration only. A major limitation of these studies was the subject selection. Most recruited patients with various medical conditions including respiratory diseases or undefined recruitment criteria, whilst some did not report the subjects' age and some had small subject numbers. Only one study performed mutation analysis to determine carrier status. No study used appropriate statistical analysis to develop a sweat chloride reference interval. The literature review yielded no studies that reliably developed reference intervals for sweat electrolyte concentrations. The limitations of the studies highlight the need for reliable age-related reference intervals for sweat electrolyte concentrations in healthy subjects.

Entities:  

Year:  2007        PMID: 17687417      PMCID: PMC1904422     

Source DB:  PubMed          Journal:  Clin Biochem Rev        ISSN: 0159-8090


  30 in total

1.  SWEAT CHLORIDE CONCENTRATION; A COMPARATIVE STUDY IN CHILDREN WITH BRONCHIAL ASTHMA AND WITH CYSTIC FIBROSIS.

Authors:  R GHARIB; H A JOOS; L B HILTY
Journal:  Am J Dis Child       Date:  1965-01

2.  'Sweat test' results in normal persons of different ages compared with families with fibrocystic disease of the pancreas.

Authors:  C M ANDERSON; M FREEMAN
Journal:  Arch Dis Child       Date:  1960-12       Impact factor: 3.791

3.  A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis.

Authors:  L E GIBSON; R E COOKE
Journal:  Pediatrics       Date:  1959-03       Impact factor: 7.124

4.  The electrolyte content of the sweat in fibrocystic disease of the pancreas.

Authors:  B W WEBB; P T FLUTE; M J SMITH
Journal:  Arch Dis Child       Date:  1957-04       Impact factor: 3.791

5.  A simple method of sweat collection with analysis of electrolytes in patients with fibrocystic disease of the pancreas, and their families.

Authors:  C M ANDERSON; M FREEMAN
Journal:  Med J Aust       Date:  1958-03-29       Impact factor: 7.738

6.  Sweat electrolyte disturbances associated with childhood pancreatic disease.

Authors:  P A DI SANT'AGNESE; R C DARLING; G A PERERA; E SHEA
Journal:  Am J Med       Date:  1953-12       Impact factor: 4.965

7.  Sweat testing following newborn screening for cystic fibrosis.

Authors:  J Massie; K Gaskin; P Van Asperen; B Wilcken
Journal:  Pediatr Pulmonol       Date:  2000-06

8.  Sweat testing for the diagnosis of cystic fibrosis: practical considerations.

Authors:  V A LeGrys
Journal:  J Pediatr       Date:  1996-12       Impact factor: 4.406

9.  The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era.

Authors:  Avantika Mishra; Ronda Greaves; John Massie
Journal:  Clin Biochem Rev       Date:  2005-11

10.  Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis.

Authors:  P M Farrell; R E Koscik
Journal:  Pediatrics       Date:  1996-04       Impact factor: 7.124

View more
  10 in total

1.  Atypical pyogenic brain abscess evaluation by diffusion-weighted imaging: diagnosis with multimodality MR imaging.

Authors:  Mustafa Ozbayrak; Ozden Sila Ulus; Mehmet Zafer Berkman; Sesin Kocagoz; Ercan Karaarslan
Journal:  Jpn J Radiol       Date:  2015-08-15       Impact factor: 2.374

2.  Laboratory medicine best practice guideline: vitamins a, e and the carotenoids in blood.

Authors:  Ronda F Greaves; Gerald A Woollard; Kirsten E Hoad; Trevor A Walmsley; Lambro A Johnson; Scott Briscoe; Sabrina Koetsier; Tamantha Harrower; Janice P Gill
Journal:  Clin Biochem Rev       Date:  2014-05

3.  Australasian Guideline (2nd Edition): an Annex to the CLSI and UK Guidelines for the Performance of the Sweat Test for the Diagnosis of Cystic Fibrosis.

Authors:  John Massie; Ronda Greaves; Michael Metz; Veronica Wiley; Peter Graham; Samantha Shepherd; Richard Mackay
Journal:  Clin Biochem Rev       Date:  2017-11

Review 4.  Working Up a Good Sweat - The Challenges of Standardising Sweat Collection for Metabolomics Analysis.

Authors:  Joy N Hussain; Nitin Mantri; Marc M Cohen
Journal:  Clin Biochem Rev       Date:  2017-02

Review 5.  Atypical cystic fibrosis and CFTR-related diseases.

Authors:  Shruti M Paranjape; Pamela L Zeitlin
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

6.  Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.

Authors:  Philip M Farrell; Beryl J Rosenstein; Terry B White; Frank J Accurso; Carlo Castellani; Garry R Cutting; Peter R Durie; Vicky A Legrys; John Massie; Richard B Parad; Michael J Rock; Preston W Campbell
Journal:  J Pediatr       Date:  2008-08       Impact factor: 4.406

7.  Comparison of classic sweat test and crystallization test in diagnosis of cystic fibrosis.

Authors:  Fatemeh Farahmand; Nooshin Sadjadei; Mohammad-Taghi Haghi-Ashtiani; Vajiheh Modaresi; Nima Rezaei; Bahar Pakseresht
Journal:  Iran J Pediatr       Date:  2012-03       Impact factor: 0.364

8.  Quality of sweat test (ST) based on the proportion of sweat sodium (Na) and sweat chloride (Cl) as diagnostic parameter of cystic fibrosis: are we on the right way?

Authors:  Alethéa Guimarães Faria; Fernando Augusto Lima Marson; Carla Cristina de Souza Gomez; Maria Ângela Gonçalves de Oliveira Ribeiro; Lucas Brioschi Morais; Maria de Fátima Servidoni; Carmen Sílvia Bertuzzo; Eulália Sakano; Maura Goto; Ilma Aparecida Paschoal; Mônica Corso Pereira; Gabriel Hessel; Carlos Emílio Levy; Adyléia Aparecida Dalbo Contrera Toro; Andressa Oliveira Peixoto; Maria Cristina Ribeiro Simões; Elizete Aparecida Lomazi; Roberto José Negrão Nogueira; Antônio Fernando Ribeiro; José Dirceu Ribeiro
Journal:  Diagn Pathol       Date:  2016-10-26       Impact factor: 2.644

9.  Saliva as a potential tool for cystic fibrosis diagnosis.

Authors:  Aline Cristina Gonçalves; Fernando Augusto de Lima Marson; Regina Maria de Holanda Mendonça; José Dirceu Ribeiro; Antonio Fernando Ribeiro; Ilma Aparecida Paschoal; Carlos Emílio Levy
Journal:  Diagn Pathol       Date:  2013-03-19       Impact factor: 2.644

10.  Regional variations in transepidermal water loss, eccrine sweat gland density, sweat secretion rates and electrolyte composition in resting and exercising humans.

Authors:  Nigel As Taylor; Christiano A Machado-Moreira
Journal:  Extrem Physiol Med       Date:  2013-02-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.